OR WAIT null SECS
January 03, 2017
TraceLink’s first Drug Supply, Safety and Traceability Report suggests that 19% of pharma companies, 11% of distributors, and 9% of dispensers still haven’t begun to address lot-level serialization requirements. Only 20% say their CMOs will be ready for the November 2017 deadline.
November 02, 2016
Covert and layered approaches to combat drug counterfeiting and illegal diversion strive to stay ahead of criminal enterprises.
Governments stretch limited resources to track counterfeit, diverted, and stolen pharmaceuticals globally. \
The proliferation of counterfeit medicines is nothing new to pharma; however, the scale of the problem seems to be escalating.
November 01, 2016
TraceLink launched the EU-hosted early access program to reduce the time, cost, and risk of achieving regulatory compliance for global requirements.
October 06, 2016
A report from the European Union Intellectual Property Office shows that the EU loses approximately €10.2 billion a year due to counterfeit medicines.
October 03, 2016
Pharmaceutical manufacturers and business partners are studying how Advanced Digital Ledger Technology might solve supply chain and other data transfer problems.
October 02, 2016
A number of organizations have analyzed and estimated the size of pharma’s counterfeit and diversion problem.
As criminals duplicate the latest overt security technologies, pharmaceutical manufacturers are evaluating covert and layered approaches to fight counterfeiting, theft, and illegal product diversion.